Article Details

AstraZeneca's cancer R&D exec Ferté joins Relay to run its lead asset as another bluebird exec ...

Retrieved on: 2021-05-03 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's cancer R&D exec Ferté joins Relay to run its lead asset as another bluebird exec .... View article details on hiswai:

Excerpt

Last month we found out, via Twitter, that AstraZeneca's Charles Ferté, M.D., Ph.D., senior director and global project leader of oncology R&D, was ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up